글로벌 스타이 약물 시장 - 업계 동향 및 2028년까지의 예측

시장 분석 및 Stye Drug 시장 통찰력

Data Bridge Market Research는 2021-2028년 예측 기간 동안 눈꺼풀 약이 약 5.2%의 CAGR을 보일 것이라고 분석했습니다. 전 세계적으로 눈꺼풀 인구가 계속 증가하고, 위험 관련 치료에 사용되는 약물의 등장, 실내 및 실외 알레르겐 의 유병률이 증가하는 것이 눈꺼풀 약 시장 성장에 기여하는 주요 요인입니다.

눈꺼풀 위나 아래 눈꺼풀 에 생기는 고통스러운 감염입니다 . 호르데올럼이라고도 알려진 눈꺼풀은 눈꺼풀 가장자리나 밑부분에 작은 덩어리가 생기는 질병입니다. 눈꺼풀 질환은 모든 연령대, 특히 30~50대에 만연합니다.  

증가하는 노령 인구와 더불어 증가하는 녹내장 감염 유병률은 녹내장 약물 시장 성장을 촉진하는 주요 요인입니다. 의료 인프라 개발에 대한 지출 증가와 개인 가처분 소득 증가도 시장 성장을 촉진하고 있습니다. 또한, 생명공학 및 제약 회사의 신약 및 치료법 개발을 위한 연구 개발 활동 증가는 수익성 있는 시장 성장 기회를 창출할 것입니다.

그러나 여러 회사의 특허 만료는 시장 성장에 큰 도전이 될 것입니다. 시장에서 제네릭 약물의 가용성은 시장 성장률을 더욱 떨어뜨릴 것입니다. 저개발 경제권에서 눈꺼풀 질환에 대한 인식 부족은 시장 성장률을 더욱 도전할 것입니다.   

This stye drug market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on stye drug market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Stye Drug Market Scope and Market Size

The stye drug market is segmented on the basis of type, therapy type, treatment type, drug class type, route of administration and end users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• Based on the type, the stye drug market has been segmented into external hordeolum and internal hordeolum.
• Based on the therapy type, the stye drug market has been segmented into antibiotic therapy and eye warming therapy.
• On the basis of treatment type, the stye drug market is segmented into medication and surgery.
• On the basis of drug class type, the stye drug market is segmented into antibiotics and ophthalmic steroids.
• On the basis of route of administration, the stye drug market is segmented into oral, topical and others.
• On the basis of end users, the stye drug market is segmented into hospitals, homecare, specialty clinics and others.

Stye Drug Market Country Level Analysis

The stye drug market is analysed and market size insights and trends are provided by country, type, therapy type, treatment type, drug class type, route of administration and end users as referenced above.

The countries covered in the stye drug market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

Asia-Pacific is projected to score highest growth rate and exhibit the highest CAGR for the forecast period. This is because of the rising expenditure to develop healthcare infrastructure coupled with growth and expansion of life sciences industry. Rising prevalence of stye disease is another factor fostering the growth of the market in this region.

The country section of the stye drug market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Stye drug market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Stye Drug Market Share Analysis

The stye drug market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to core stye drug market.

The major players covered in the stye drug market report are Similasan, Bausch & Lomb Pvt Ltd., F. Hoffmann-La Roche Ltd, Novartis AG, Astrazeneca, Pfizer Inc., Sanofi, Johnson & Johnson Services, Inc., AbbVie Inc., Allergan, Merck & Co., Inc., Amgen Inc., DAIICHI SANKYO COMPANY, LIMITED., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., XOMA Corporation., Regeneron Pharmaceuticals Inc., Takeda Pharmaceutical Company Limited., Clearside Biomedical, Inc. and Ligand Pharmaceuticals Incorporated among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

SKU-43571